Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in! Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow
Download Free PDF

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Access icon
Neurology Seizures

Letter to the Editor December 15, 1998

Edema Associated With Addition of Risperidone to Valproate Treatment

Richard D. Sanders ; Douglas S. Lehrer

J Clin Psychiatry 1998;59(12):689-690

Article Abstract

Sir: We report a second case of acute generalized edema following the addition of risperidone to a regimen involving valproate.

 

Download Free PDF

This PDF is free for all visitors!

Save Save

Share Share

Cite Cite

Related News Articles

How PTSD Reshapes the Brain at the Cellular Level Grip Strength Offers Clues to Brain Health in Early Psychosis Infant Brain Wiring Could Predict Future Emotional Health

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

A 65-Year-Old Man With Amyotrophic Lateral Sclerosis and Psychiatric Distress The Psychological Burden of ALS, the Enduring Strength of People Living With ALS, and the Tools We Can Use to Help Diagnosing and Treating Alzheimer Disease During the Early Stage

Related PCC Articles

Recognizing Cotard Syndrome in the ED Sequelae of Adverse Childhood Experiences Neuropsychiatric Presentation of Vitamin B12 Deficiency

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Related Articles

PCC
Insights Into Poststroke Depression
Letter to the Editor

Insights Into Poststroke Depression

August 31, 2023

The authors shed light on risk factors, purported mechanisms, diagnostic tips, and treatment options for poststroke depression.
Ahmed Naguy , Bibi Alamiri
PCC
Neuropsychiatric Manifestations of Mpox
Letter to the Editor

Neuropsychiatric Manifestations of Mpox

April 18, 2023

Rujittika Mungmunpuntipantip, PhD, and Viroj Wiwanitkit, MD, comment on a report recently published in the PCC.
Rujittika Mungmunpuntipantip , Viroj Wiwanitkit
PCC
Comment on Huntington’s Disease With Psychotic Features
Letter to the Editor

Comment on Huntington’s Disease With Psychotic Features

March 7, 2023

Herwig Lange, MD, comments on a report previously published in the PCC.
Herwig Lange

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap